You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
Transcatheter aortic valve implantation (TAVI) is a minimally invasive, catheter-based procedure to replace the function of the aortic valve.
TAVI may be an excellent option for certain patients because the prevalence of aortic stenosis and co-morbidities increase the risks associated with surgical aortic valve implantation (SAVI).1 Without intervention, the average symptomatic patient life expectancy is 2 to 5 years.2
Schwartz F, et al. The effect of aortic valve replacement on survival Circulation. 1982:66:1105-1110.
Lester SJ, Heilbron B, Gin K, et al. The natural history and rate of progression of aortic stenosis. Chest 1998; 113:1109-14.
Medtronic data on file.